Proove Bioscience

Quote

anonymous said:
Michael Thatcher was appointed as Receiver for Proove Biosciences, a $39 million revenue healthcare services company with operations in over 20 states. Proove was involved in the research, development and commercialization of physician-ordered tests to assist in the prevention of drug & alcohol abuse with a central focus on opioid addiction. Thatcher managed the wind-down and sale of a clinical lab and complex IP. Remaining assets were ultimately purchased by the secured lender via a credit bid on their claim.

In November of 2017, Mr. Thatcher initiated a civil suit against Proove’s sole shareholder, President and CEO in Superior Court of California, Orange County for various breaches of duty and other bad-faith acts. Discovery is underway with depositions set for early October 2018 and a trial date to occur in early 2019.
Click to expand...
.
 









anonymous said:
Michael Thatcher was appointed as Receiver for Proove Biosciences, a $39 million revenue healthcare services company with operations in over 20 states. Proove was involved in the research, development and commercialization of physician-ordered tests to assist in the prevention of drug & alcohol abuse with a central focus on opioid addiction. Thatcher managed the wind-down and sale of a clinical lab and complex IP. Remaining assets were ultimately purchased by the secured lender via a credit bid on their claim.

In November of 2017, Mr. Thatcher initiated a civil suit against Proove’s sole shareholder, President and CEO in Superior Court of California, Orange County for various breaches of duty and other bad-faith acts. Discovery is underway with depositions set for early October 2018 and a trial date to occur in early 2019.
Click to expand...
.
 









anonymous said:
Michael Thatcher was appointed as Receiver for Proove Biosciences, a $39 million revenue healthcare services company with operations in over 20 states. Proove was involved in the research, development and commercialization of physician-ordered tests to assist in the prevention of drug & alcohol abuse with a central focus on opioid addiction. Thatcher managed the wind-down and sale of a clinical lab and complex IP. Remaining assets were ultimately purchased by the secured lender via a credit bid on their claim.

In November of 2017, Mr. Thatcher initiated a civil suit against Proove’s sole shareholder, President and CEO in Superior Court of California, Orange County for various breaches of duty and other bad-faith acts. Discovery is underway with depositions set for early October 2018 and a trial date to occur in early 2019.
Click to expand...
.
 






anonymous said:
Joe Matthews is at Super Bowl with Pats Jersey. Just saw it on his gram. His residuals are still coming in I guess. Lucky guy.
Click to expand...
Joe Matthews, please stop posting things about yourself as if your doing great. No one believes anything you post, yes we know it’s you posting. You and Brian are living in borrowed time right now. Justice is around the corner..
 



anonymous said:
Michael Thatcher was appointed as Receiver for Proove Biosciences, a $39 million revenue healthcare services company with operations in over 20 states. Proove was involved in the research, development and commercialization of physician-ordered tests to assist in the prevention of drug & alcohol abuse with a central focus on opioid addiction. Thatcher managed the wind-down and sale of a clinical lab and complex IP. Remaining assets were ultimately purchased by the secured lender via a credit bid on their claim.

In November of 2017, Mr. Thatcher initiated a civil suit against Proove’s sole shareholder, President and CEO in Superior Court of California, Orange County for various breaches of duty and other bad-faith acts. Discovery is underway with depositions set for early October 2018 and a trial date to occur in early 2019.
Click to expand...
.
 



anonymous said:
Michael Thatcher was appointed as Receiver for Proove Biosciences, a $39 million revenue healthcare services company with operations in over 20 states. Proove was involved in the research, development and commercialization of physician-ordered tests to assist in the prevention of drug & alcohol abuse with a central focus on opioid addiction. Thatcher managed the wind-down and sale of a clinical lab and complex IP. Remaining assets were ultimately purchased by the secured lender via a credit bid on their claim.

In November of 2017, Mr. Thatcher initiated a civil suit against Proove’s sole shareholder, President and CEO in Superior Court of California, Orange County for various breaches of duty and other bad-faith acts. Discovery is underway with depositions set for early October 2018 and a trial date to occur in early 2019.
Click to expand...
.
 









anonymous said:
Brian Meshkin fabricated and deceived the investors to get them to invest in his phony scam company. They will take every last cent he has to make up for his deception. At least, they have the power and means to go after him unlike the employees, doctors and sales reps he scammed.

The FBI charges are not far behind.
Click to expand...
.
 



anonymous said:
Brian Meshkin fabricated and deceived the investors to get them to invest in his phony scam company. They will take every last cent he has to make up for his deception. At least, they have the power and means to go after him unlike the employees, doctors and sales reps he scammed.

The FBI charges are not far behind.
Click to expand...
.
 



anonymous said:
Brian Meshkin fabricated and deceived the investors to get them to invest in his phony scam company. They will take every last cent he has to make up for his deception. At least, they have the power and means to go after him unlike the employees, doctors and sales reps he scammed.

The FBI charges are not far behind.
Click to expand...
.
 






anonymous said:
Michael Thatcher was appointed as Receiver for Proove Biosciences, a $39 million revenue healthcare services company with operations in over 20 states. Proove was involved in the research, development and commercialization of physician-ordered tests to assist in the prevention of drug & alcohol abuse with a central focus on opioid addiction. Thatcher managed the wind-down and sale of a clinical lab and complex IP. Remaining assets were ultimately purchased by the secured lender via a credit bid on their claim.

In November of 2017, Mr. Thatcher initiated a civil suit against Proove’s sole shareholder, President and CEO in Superior Court of California, Orange County for various breaches of duty and other bad-faith acts. Discovery is underway with depositions set for early October 2018 and a trial date to occur in early 2019.
Click to expand...
.
 



What I find interesting is that Khanh is listed on their website as a partner, yet, he’s been traipsing across Asia for months now.
Kinda hard to be a partner when you’re on permanent holiday.
Like everything else with Brian, I’m sure it’s all a front.
 






Top Bottom
Back
Quote